Blogchevron-rightArticle

409A Valuations Explained by Someone Who's Read Hundreds of Them

September 22, 2026
409A Valuations Explained by Someone Who's Read Hundreds of Them

TL;DR: A 409A valuation is an independent appraisal of your company's common stock, and the IRS requires one before you can grant stock options without triggering tax penalties. It typically costs anywhere from free to $15,000 depending on the provider, stays valid for 12 months or until a "material event" resets the clock, and gets recalculated using methods like the OPM backsolve or PWERM. The mechanics are well documented elsewhere. What's less documented is where founders actually get this wrong, which is what this piece is for.


I've sat on the other side of the table for a lot of these. Before I ran business operations at Warp, I was an investor, and part of that job was reading 409A reports as part of diligence: checking whether a company's valuation history made sense, whether the methodology held up, and whether the board actually understood what they'd approved. Most founders treat their 409A as a form to file and forget, but that's the mistake. A sloppy 409A history is one of the first things a sharp investor or acquirer's counsel will flag, and it's entirely avoidable.

What a 409A Valuation Actually Is

A 409A valuation determines the fair market value (FMV) of your company's common stock. Not the value investors are paying for preferred shares in your latest round. Not the number in your pitch deck. Specifically, the common stock, the class your employees hold or will hold through stock options.

That FMV becomes your strike price floor. Under Section 409A of the Internal Revenue Code, employees can't be granted stock options priced below fair market value on the grant date. If they are, the IRS treats the difference as deferred compensation and taxes it immediately, plus a 20% penalty. This isn't a theoretical risk. For a company with a wide gap between its old 409A price and its actual value, that penalty can run well into six figures across a single batch of grants.

The reason common stock gets its own valuation instead of just using the price investors paid is straightforward: preferred stock comes with rights common stock doesn't have. Liquidation preferences, anti-dilution protection, board seats, and other terms mean preferred shares are worth more than common shares of the same company. A 409A backs out that gap. In practice, early-stage common stock FMV usually lands somewhere between 20% and 60% of the most recent preferred price, depending on stage, cap structure, and how much preference stacking has built up.

How the Valuation Gets Calculated

Three methods show up in almost every 409A report, and which one applies depends entirely on your stage:

OPM backsolve. The standard method once you've closed a priced round. The appraiser takes the price investors just paid for preferred stock and works backward, using an option pricing model to allocate value across every class of stock on your cap table and account for each class's specific rights. This is the most defensible method because it's anchored to an actual arm's-length transaction, which is exactly why a new priced round almost always triggers a fresh 409A.

PWERM (probability-weighted expected return method). Used more often at later stages, when a company can reasonably model multiple future outcomes (IPO, acquisition, continued private operation) and assign probabilities to each. More complex, and generally overkill for an early-stage company with no real basis for those probability weightings yet.

Cost approach. Used for pre-revenue, pre-funding companies with no priced transaction to backsolve from. The appraiser essentially values the company based on assets and capital invested to date, since there's no market signal to anchor to yet.

Notably absent from that list: a straightforward discounted cash flow model. DCF requires forecasting cash flows with enough confidence to discount them, and almost no early-stage startup has that kind of forecasting reliability. If a provider is running a DCF as your primary method at seed or Series A, that's worth asking about.

What a 409A Actually Costs

Pricing varies more than founders expect, and the range tells you something about what you're buying:

  • AI-assisted or software-driven platforms: Free to roughly $699, often bundled into a broader cap table or equity management tool.
  • Boutique valuation firms: Roughly $2,000 to $5,000, typically turned around in one to three weeks.
  • Big 4 or large accounting firms: $5,000 to $15,000+, usually reserved for later-stage companies where the size of the option pool and auditor scrutiny justify the cost.

The cheapest option isn't automatically the wrong call, and the most expensive one isn't automatically the safest. What matters is whether the report holds up under IRS safe harbor standards, which requires an independent appraisal from someone with real valuation experience, not a rubber stamp. Ask any provider, regardless of price point, how they'd defend the report if it were ever audited. If they can't answer that clearly, the price you paid doesn't matter.

What Triggers a New 409A Valuation

A 409A is valid for 12 months from its effective date, but that clock resets early the moment a "material event" occurs. The most common triggers, in roughly descending order of how often they actually show up:

  1. Closing a priced equity round. By far the most common trigger. A negotiated price paid by sophisticated investors is new, hard evidence of value, and it makes your prior valuation immediately stale.
  2. A large SAFE or convertible note raise at implied terms meaningfully different from your last 409A. SAFEs and notes don't set a priced valuation the way a priced round does, so they don't automatically trigger a refresh, but a large raise at aggressive terms can still be evidence the old number no longer holds.
  3. A secondary sale or tender offer. If shares change hands at a price different from your last 409A FMV, that's a market signal the IRS expects you to account for.
  4. A serious acquisition offer or signed LOI.
  5. A major inflection in the business, positive or negative: a big revenue jump, a flagship customer win, a significant miss against plan, or a major pivot.

The practical rule most boards follow: refresh annually if nothing else happens, and refresh immediately after any priced round before granting another option. In practice, most venture-backed companies do this every 8 to 11 months, not the full 12, because something on that list usually happens before the year is up.

409A vs. Priced-Round Valuation

This is the most common point of confusion I see, even among experienced founders of their second or third company. Your Series A pre-money or post-money valuation and your 409A FMV measure two different things, and they shouldn't match.

Your round valuation reflects what investors will pay for preferred stock, priced through negotiation and shaped by market conditions when you're raising. Your 409A reflects the fair market value of common stock specifically, discounted because common stock lacks the protections preferred stock has. If your 409A comes back close to your last round's price per share, that's usually a sign something's off in the methodology, but it doesn’t actually reflect how well your company is doing.

This gap is also why timing matters so much. If you close a round on a Tuesday and grant options on Wednesday using your old (pre-round) 409A, you've almost certainly issued options below the true post-round FMV. That's not a paperwork problem. It's a compliance problem that follows every affected employee's tax return.

Where Founders Get This Wrong

A few patterns show up again and again, and most of them are avoidable with about ten minutes of planning:

  1. Granting options in the gap between closing a round and getting the new 409A back. New hires start, the board wants to move fast, and someone grants options using the stale pre-round valuation because the new report isn't back yet. Sequence it the other way: close the round, order the refreshed 409A immediately, and hold grants until it's in hand.
  2. Treating the 409A provider relationship as a commodity. Founders often shop purely on price and turnaround time, then get surprised when the report doesn't hold up to investor or auditor scrutiny at the next round. The report needs to survive contact with people who didn't write it.
  3. Not connecting the 409A to the rest of the cap table story. A 409A doesn't exist in isolation. It directly affects how much dilution your option pool creates, and how attractive (or unattractive) your equity comp looks to a candidate comparing offers. If you haven't mapped how dilution compounds across SAFEs, option pools, and priced rounds, your 409A is a number in isolation instead of part of a bigger picture.
  4. Assuming a clean 409A history doesn't matter until diligence. It matters well before that. Investors and acquirers read your valuation history the same way they read your cap table: as a signal of how carefully the company has been run. A gap-free, well-documented sequence of 409As is a small thing that quietly speeds up every future round.

One example I’ve seen time and time again is when options are granted in the gap between closing a round and updating your 409A. Let’s say a Series A company closed its round on Friday and the team wanted to extend offers to a Head of Engineering and Head of Sales candidate that same week. The internal team then ran the options using the 409A in place since the seed round months earlier. When they ran the new 409A the following Monday, the price came back at a much larger multiple on the old FMV.

Both new hires had already been granted options at the stale strike price. Under Section 409A, that gap between what they paid and true fair market value on the grant date counted as deferred compensation, taxable immediately, plus the 20% penalty. Fixing it meant amending the grants, recalculating the affected employees' tax exposure, and having an uncomfortable conversation with two new hires in their first month about a tax bill they hadn't seen coming.

The fix is simple in hindsight: change the internal policy so no grants go out between a round closing and the refreshed 409A landing. But getting the cadence or methodology wrong isn't just a paperwork footnote. It's a cost that lands on specific employees' tax returns, not just the cap table.

How This Connects to Dilution and Equity Comp

Every time your 409A moves, two things move with it. First, your strike price for new grants changes, which changes how much upside a new hire's options actually carry. A lower defensible FMV means more room for employee upside; a higher one (correctly, not artificially) means options cost employees more to exercise. Second, every option pool expansion tied to a new round is dilution, on top of whatever the round itself costs founders and early employees in ownership.

If you're heading into a raise and haven't modeled what the round, the option pool refresh, and your next 409A will do to your ownership together, run the numbers with Warp's equity dilution calculator before you sign anything. It's also worth understanding the mechanics of whatever instrument you're raising on: how a YC SAFE actually converts and what it costs you in dilution, or what a capital raise involves end to end if this is your first round. And if you're trying to extend runway without triggering a 409A refresh at all, it's worth looking at non-dilutive funding options for startups before you assume equity is the only path.

A clean 409A history, understood in context rather than filed and forgotten, is a small operational habit that pays off every time you raise, hire, or sell the company. Investors doing diligence will look at it right alongside your cap table, your burn rate, and yes, your market sizing story if you've put together a TAM, SAM, and SOM breakdown for your pitch. All of it signals the same thing: whether this is a company that runs its numbers with intent, or one that's guessing.

FAQ Section

What is a 409A valuation, in simple terms?

A 409A valuation is an independent appraisal of your private company's common stock, required under IRC Section 409A before you grant stock options. It sets the minimum legal strike price for those options and keeps you compliant with IRS rules on equity compensation.

How much does a 409A valuation cost?

Costs range from free (AI-assisted platforms bundled into equity tools) to $15,000 or more (large accounting firms), with boutique valuation firms typically charging $2,000 to $5,000. Price correlates loosely with company stage and complexity, not necessarily with defensibility.

How long is a 409A valuation valid?

Twelve months from the effective date, or until a material event occurs, whichever comes first. Closing a priced funding round is the most common event that resets the clock early.

What triggers a new 409A valuation?

A priced equity round is the clearest and most common trigger. Others include a large SAFE or note raise at meaningfully different implied terms, a secondary sale, a serious acquisition offer, or a major shift in revenue or business performance.

Does a 409A valuation match my company's funding round valuation?

No, and it shouldn't. Your round valuation prices preferred stock based on investor negotiation. Your 409A prices common stock, which is worth less because it lacks the liquidation preferences and protections preferred stock carries. Early-stage common stock FMV commonly lands at 20% to 60% of the preferred price.

What happens if I skip getting a 409A valuation?

If you grant stock options without a valid 409A and the strike price turns out to be below fair market value, the IRS can tax the affected employees on the spread immediately, plus a 20% penalty. For companies with a meaningful valuation gap, this can total well over $100,000 across a single grant batch.